Brain Olfactory Pathways in Prader-Willi Syndrome
ConditionPrader-Willi Syndrome
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-7
SponsorUniversity Hospital, Toulouse
About this trial
Studying the cerebral activity of children with Prader-Willi Syndrom (PWS) when the study propose to them nasal activations.
Eligibility criteria
Qualifiers
child with a genetically confirmed diagnosis of PWS and for whom the genetic subtype (deletion or non deletion) has been identified
Child aged between 5 and 7 years
Child with a planned hospitalization at the Toulouse reference center for PWS
Disqualifiers
Presence of a contraindication to MRI
Allergy to any of the fragrances used in the olfactory test
Presence of an ENT infection such as rhinitis or sinusitis on the day of inclusion
Reported anosmia
Trial design
Treatments tested in this trial
- olfactory stimulation
- functional MRI
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
University Hospital, Toulouse
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
Source ClinicalTrials.gov